Inventor · disambiguated record
Edward P. Feener
Also filed as: FEENER EDWARD · FEENER EDWARD P · FEENER EDWARD PAUL
2 granted patents·10 pending applications·8 citations·filing 2006–2022
53Inventor score
Files withKALVISTA PHARMACEUTICALS LTD5AIELLO LLOYD P2FEENER EDWARD P2JOSLIN DIABETES CT2JOSLIN DIABETES CENTER INC1
Top patents by PatentIndex Score
12 records- 0173US8658685B2Methods for treatment of kallikrein-related disordersAIELLO LLOYD P·Filed 2009·Granted Feb 25, 2014·5 cites·24 claims
- 0272US8841259B2Compositions and methods for treating vascular permeabilityFEENER EDWARD P·Filed 2006·Granted Sep 23, 2014·3 cites·19 claims
- 0355US2024122909A1Treatments of hereditary angioedemaKALVISTA PHARMACEUTICALS LTD·Filed 2022·Application pending·0 cites
- 0454US2023381162A1Treatments of angioedemaKALVISTA PHARMACEUTICALS LTD·Filed 2021·Application pending·0 cites
- 0551US2010119512A1Methods of diagnosing, treating, and preventing increased vascular permeabilityJOSLIN DIABETES CT·Filed 2008·Application pending·0 cites
- 0651US2011318359A1Method for reducing blood pressure using inhibitors of plasma kallikreinFEENER EDWARD P·Filed 2009·Application pending·0 cites
- 0748US2022226293A1Treatments of angioedemaKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 0848US2022401390A1Treatments of diabetic macular edema and impaired visual acuityKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 0947US2014348850A1Method for reducing blood pressure using inhibitors of plasma kallikreinJOSLIN DIABETES CT·Filed 2014·Application pending·0 cites
- 1046US2022218680A1Treatments of hereditary angioedemaKALVISTA PHARMACEUTICALS LTD·Filed 2020·Application pending·0 cites
- 1138US2015141497A1Methods for modulating kallikrein (klkb1) expressionJOSLIN DIABETES CENTER INC·Filed 2013·Application pending·0 cites
- 1238US2009069231A1Compositions and methods for treating diabetic eye diseaseAIELLO LLOYD P·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →